Menu
Search
|

Menu

Close
X

Mayinglong Pharmaceutical Group Co Ltd 600993.SS (Shanghai Stock Exchange)

14.34 CNY
+0.08 (+0.56%)
As of Nov 15
chart
Previous Close 14.26
Open 14.33
Volume 657,317
3m Avg Volume 2,203,222
Today’s High 14.43
Today’s Low 14.26
52 Week High 24.99
52 Week Low 12.52
Shares Outstanding (mil) 431.05
Market Capitalization (mil) 6,099.41
Forward P/E 29.75
Dividend (Yield %) 0.23 ( 1.63 )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
1.00 Mean rating from 1 analysts

KEY STATS

Revenue (mm, CNY)
FY18
1,592
FY17
1,751
FY16
2,103
FY15
1,784
EPS (CNY)
FY18
0.280
FY17
0.742
FY16
0.581
FY15
0.515
*Note: Units in Millions of Renminbi
**Note: Units in Renminbi

KEY RATIOS

Price to Earnings (TTM)
vs sector
29.75
29.53
Price to Sales (TTM)
vs sector
2.83
22.95
Price to Book (MRQ)
vs sector
2.75
4.15
Price to Cash Flow (TTM)
vs sector
--
20.94
Total Debt to Equity (MRQ)
vs sector
0.89
15.47
LT Debt to Equity (MRQ)
vs sector
0.17
11.13
Return on Investment (TTM)
vs sector
8.65
13.00
Return on Equity (TTM)
vs sector
9.48
14.69

EXECUTIVE LEADERSHIP

Ping Chen
Chairman of the Board, Since 1995
Salary: --
Bonus: --
Guangsheng Zeng
Vice Chairman of the Board, Since
Salary: --
Bonus: --
Lingli Chen
Chief Financial Officer, Since 2013
Salary: --
Bonus: --
Youzhang Xia
Chief Administrative Officer, Secretary of the Board, Since 2010
Salary: --
Bonus: --
Guangxiang Su
General Manager, Director, Since 2006
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Pharmaceuticals
Address:

No. 100, Nanhu Zhoujiawan, Wucha
WUHAN   HUB   430064

Phone: +8627.87291519

Mayinglong Pharmaceutical Group Co., Ltd. is a China-based company, principally engaged in pharmaceutical production, retailing and wholesaling businesses. The Company's pharmaceutical products are classified as drugs for hemorrhoid, including diosmin tablets, suppositories, pastes and granules, among others; drugs for cough, including levodropropizine oral solution and compound glycyrrhiza oral solution, as well as drugs for skin injuries, including products such as erythromycin ointment. The Company also provides specialty drugs. The Company is also engaged in the production and distribution of eye cream products with the brand named Mayinglong BaBao, as well as the provision of hospital clinical service. The Company distributes its products mainly in domestic markets.

SPONSORED STORIES